Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September.

Piramal Buys 5 Injectable Generics from J&J

India-based Piramal pays Johnson & Johnson $155 million for a suite of anesthesia and pain management drugs.

Piramal / Image: FiercePharma
Piramal / Image: FiercePharma

An October 11th FiercePharma article covered a deal inked between Piramal and Johnson & Johnson in which the former paid $155 million up front for five generic pain drugs. In Paramal’s third healthcare buyout of 2016, it obtains all technical and marketing rights to the drugs, while J&J’s Janssen division will continue to manufacture them for a minimum of three years.

The deal gives Piramal firm footing in the generic injectable drug market, which is valued at $20 billion and relatively immune to the competition and pricing pressure that plagues the oral market. Four of the five drugs included in the deal are opioids, which face more hurdles for approval and therefore face fewer rivals. Should the drugs hit sales targets over the next 30 months, J&J will receive another $20 million in the deal.

Break out of the ordinary: see what’s new in life sciences packaging
At PACK EXPO Las Vegas, you’ll see machinery in action and new tech from 2,300 suppliers, collaborate with experts and explore transformative solutions. Join us in September to experience a breakthrough for life sciences products.
REGISTER NOW & SAVE!
Break out of the ordinary: see what’s new in life sciences packaging
List: Digitalization Companies From PACK EXPO
Looking for CPG-focused digital transformation solutions? Download our editor-curated list from PACK EXPO featuring top companies offering warehouse management, ERP, digital twin, and MES software with supply chain visibility and analytics capabilities—all tailored specifically for CPG operations.
Download Now
List: Digitalization Companies From PACK EXPO